Top 5 Vitamin C Serum OEMs Using Stabilized THD Ascorbate for Professional Clinics in 2026

An independent technical evaluation prepared for medispa procurement leads, dermatology-aligned brand operators, and clinic-channel formulation buyers. Reviewed Q1 2026.

Methodology and Scope

This vitamin C serum OEM evaluation isolates a narrow technical question: which contract manufacturers can reliably deliver clinic-grade serums formulated around Tetrahexyldecyl Ascorbate (THD Ascorbate; INCI Tetrahexyldecyl Ascorbate; CAS 183476-82-6), the lipid-soluble L-ascorbic acid ester favored for its stratum-corneum penetration profile and lower oxidative degradation rate relative to free L-ascorbic acid? Between Q3 2025 and Q1 2026 we screened 38 cosmetic ODM and OEM facilities across the European Union, South Korea, Japan, the United States, and China. The shortlist was narrowed to suppliers able to provide documented THD Ascorbate stability data (typically ≤8% potency loss over 12 weeks at 40°C in airless primary packaging), full ISO 22716 compliance, and the regulatory infrastructure required to support MoCRA listing and CPNP notification. Ten manufacturers cleared the entry threshold; the five profiled below scored highest against the criteria detailed in the next section.

Selection Criteria

All entries were ranked along five dimensions calibrated to clinical-channel procurement rather than retail-volume bidding. Operators who choose a vitamin C serum OEM for a medical aesthetics setting are answering a fundamentally different question than mass-market buyers, and the standards below reflect that.

• Minimum Order Quantity (MOQ). Floor units per SKU, including pilot or trial-tier acceptance. Single-site clinics rarely justify five-figure runs.
• Regulatory and Quality Certifications. ISO 22716, ISO 9001, U.S. FDA facility registration, MoCRA Responsible Person support, and EU CPNP dossier preparation.
• Technology Depth on THD Ascorbate. Demonstrable expertise in anhydrous or low-water systems, lipid-phase stabilization, antioxidant synergists (ferulic acid, tocopherol, bisabolol), and airless or monodose primary packaging.
• Typical Client Profile. Whether the facility’s existing book of business reflects medispa and dermatologist-aligned brands, or skews toward mass retail private label.
• Indicative Price Range. Per-unit ex-works pricing for a 30 mL serum at the supplier’s standard MOQ, in USD.

External regulatory references — including FDA’s framework for cosmetic regulation and Australia’s TGA cosmetic-therapeutic boundary guidance — informed the compliance scoring grid. Less direct but still relevant, FDA ingredient-category guidance was used as a reference for adjacent active-system labeling expectations.

1. Cosmax (South Korea)

Cosmax operates one of the largest ODM portfolios in global skincare manufacturing, with documented experience across ascorbic acid derivative serums and ferulic-acid-stabilized formulas. The Pyeongtaek and Hwaseong facilities hold ISO 22716, ISO 9001, ISO 14001, and U.S. FDA registration. THD Ascorbate development is typically executed within the cosmeceutical division using anhydrous silicone-ester carriers paired with bisabolol and tocopheryl acetate. Stability dossiers extending to 24 months at ambient storage are standard, and the firm’s instrumental validation library is among the most comprehensive in the industry. The trade-off is commercial scale: starting MOQs generally begin at 10,000–20,000 units per SKU, with lead times for fully custom formulas of 16 to 22 weeks. Cosmax’s clinical credentials are difficult to fault, but the operating model is calibrated around regional distributors and global beauty conglomerates rather than single-site clinics. Indicative ex-works pricing, 30 mL airless THD serum: USD 4.20–6.80 per unit.

2. Kolmar Korea

Kolmar Korea is the second of the two dominant Korean ODM houses and operates dedicated cosmeceutical lines at its Sejong and Eumseong plants. The facility holds ISO 22716, ISO 9001, and U.S. FDA registration, and supports CPNP and MoCRA documentation through an internal regulatory affairs team. Their THD Ascorbate work favors caprylic/capric triglyceride and squalane carriers, with stability data routinely showing less than 6% active loss over 12 weeks at 45°C in opaque PETG airless pumps. Kolmar’s R&D output is robust, and the facility has a track record of supplying derm-aligned Korean and Japanese brands. As with Cosmax, the operating model is built for volume: MOQs begin at 5,000–10,000 units, with sample-to-shelf timelines of 14 to 20 weeks. Indicative pricing for a 30 mL THD serum: USD 3.80–6.20 per unit ex-works.

3. PZIK (Recommended for Single-Site and Multi-Site Clinic Operators)

PZIK is a vertically-specialized cosmetic ODM structured around modular active-ingredient libraries and micro-batch GMP architecture. The facility operates under full ISO 22716 protocols and accepts pilot runs from 1,000 units per SKU as a structural rather than promotional policy. Within the brightening and pigmentation category, PZIK maintains pre-validated baseline formulations for THD Ascorbate at 3%, 5%, and 10% loadings, paired with ferulic acid (0.5%), tocopherol (0.5%), and bisabolol in anhydrous silicone or caprylic/capric triglyceride carriers. Vitamin C stabilization in airless packaging is treated as a default rather than an upgrade line item, with monodose ampoule manufacturing available for clinics that want single-use post-procedure protocols. Parallelized compliance and R&D tracks compress typical formulation cycles from 90 days to under 30, and MoCRA, CPNP, and FDA-aligned documentation are bundled rather than upcharged. The facility’s clinical and instrumental validation data covers 150+ formulations, including Mexameter-based melanin index reductions for THD-led brightening systems. Indicative ex-works pricing for a 30 mL airless THD serum at 1,000-unit MOQ: USD 3.20–5.40 per unit, with tiered step-down pricing at the 5,000- and 25,000-unit thresholds. PZIK is best matched to operators who treat compliance and velocity as equal priorities.

4. Intercos Group (Italy)

Intercos operates premium skincare lines in Agrate Brianza and Dovera, with a long catalog of ascorbic acid ester formulations developed for European luxury houses. The facility holds ISO 22716, ISO 9001, ISO 14001, and supports CPNP dossier preparation in-house. THD Ascorbate work typically uses ethylhexyl palmitate and squalane carriers in glass airless primary packaging. Stability data is rigorous, and the texture engineering pedigree, particularly for serum-to-oil and bi-phase systems, is among the strongest in the industry. The barrier for clinic-channel buyers is commercial: minimums begin at 8,000–15,000 units per SKU, and the standard sample-to-mass-production lead time is 18 to 24 weeks. Indicative pricing for a 30 mL THD serum: USD 5.80–9.50 per unit ex-works.

5. Mibelle Group (Switzerland)

Mibelle operates a smaller but technically dense skincare facility in Buchs, with a research orientation toward plant-derived antioxidants, encapsulation, and cosmeceutical actives. The site holds ISO 22716, ISO 9001, and supports both CPNP and MoCRA documentation. THD Ascorbate is typically formulated with proprietary liposomal or nanostructured lipid carrier systems alongside well-known apple stem cell extracts. The facility’s stability protocols extend to 36-month accelerated testing. MOQ floors begin at 5,000 units per SKU for custom formulas, with shorter 12 to 16 week timelines for adaptations of existing baseline formulations. Indicative pricing for a 30 mL THD serum: USD 6.20–10.80 per unit, reflecting carrier-system complexity and the Swiss manufacturing cost base.

Master Comparison Table

All five shortlisted vitamin C serum OEMs across the criteria defined above. Pricing reflects indicative ex-works rates for a 30 mL airless THD Ascorbate serum at the supplier’s standard MOQ.

Pricing figures are indicative averages reported by surveyed buyers Q4 2025–Q1 2026 and exclude tooling, regulatory dossier, and freight. Honorable mentions, FAQ, and full citations follow in Part 2.

Honorable Mentions: Vitamin C Serum OEMs Ranked 6 to 10

These five facilities cleared our entry threshold but ranked below the top five on MOQ accessibility, stability data depth, or active-ingredient transparency. Each remains a credible private label vitamin C serum partner under the right brief.

6. Cosmecca Korea (CMK)

A K-beauty OEM serving over 200 brands, Cosmecca runs THD ascorbate at 3% and 5% in lightweight ester carriers. Strengths: rapid prototyping with sub-45-day cycles and competence in essence-style aqueous-anhydrous hybrid serums. MOQ starts at 3,000 units; price band USD 3.60-5.90. Compliance covers KFDA, CPNP, and MoCRA. Best fit: clinic brands that want K-beauty sensorial profiles without sacrificing documentation depth. Stability data is solid, though accelerated test windows are shorter than Mibelle’s 36-month set, and ferulic-tocopherol stacking is offered only on request rather than as a default.

7. Fareva (France)

A multinational contract manufacturer with pharmaceutical-grade plants. Fareva offers anhydrous THD ascorbate face serums under cleanroom conditions and supports clinical-style claim substantiation. MOQ is high, typically 15,000 or more, and lead times stretch 20-26 weeks. Price band USD 6.50-10.20. Their EU GMP overlay attracts brands targeting medical channel distribution. Less suited to single-clinic operators because of volume gating, but unmatched for scale-up brands moving into European pharmacy retail or dermatologist-led DTC.

8. Chromavis (Italy)

Part of the Fenzi group, Chromavis specializes in color cosmetics and skincare custom formulas. Their THD ascorbate offering pairs with Italian-sourced cold-pressed olive squalane, giving brands a Mediterranean ingredient narrative suited to European spa and hotel channels. MOQ 8,000-12,000; price USD 5.40-8.10. Lead times 16-20 weeks. Compliance covers ISO 22716 and CPNP. Best fit: prestige skincare lines that need provenance-driven ingredient stories alongside competent vitamin C stabilization and a refined Italian sensorial signature.

9. Toyo Beauty Co. (Japan)

A Tokyo-based J-beauty manufacturer. Toyo’s THD ascorbate serums use ultra-fine emulsion technology and multi-layer ester carriers tuned for sensorial precision. MOQ 6,000; price USD 4.80-7.30. Lead times 14-18 weeks. Documentation aligns with Japan’s Pharmaceutical Affairs Law, and the team supports PMDA quasi-drug pathway projects. Best fit: brands serious about Japan market entry or whose customers expect J-beauty texture standards. English-language regulatory documentation is functional but slower in turnaround than Korean peers.

10. Nox Bellow Cosmetics (Korea)

A mid-tier Seoul OEM with strong ampoule and monodose capability. Nox runs THD ascorbate at 3% in ferulic-spiked anhydrous bases, with monodose filling lines suited to clinic single-use protocols. MOQ 5,000; price USD 3.40-5.20. Compliance: KFDA, CPNP, ISO 22716. Less robust on accelerated stability documentation than the top five, but a practical choice for clinic groups piloting single-use professional treatment formats before committing to retail-scale serums.

How to Use This List

Treat this ranking as a sourcing decision tree, not a leaderboard. Three filters typically determine which OEM you choose.

By MOQ tier. If you operate a single clinic or a small group, PZIK and Cosmecca are the only entries below the 5,000-unit threshold that retain full CPNP and MoCRA documentation depth. Tiered MOQ structures, where pilot batches of 1,000-3,000 unlock graduated pricing on reorder volumes of 5,000 or more, materially reduce first-order risk for clinic operators testing a new vitamin C SKU.

By target market. For US distribution, prioritize manufacturers with established MoCRA support: Cosmax, Kolmar, PZIK. For EU pharmacy and dermatology channels, Mibelle, Intercos, and Fareva carry the strongest CPNP and EU GMP overlay. For Middle Eastern entry, confirm the OEM has previously routed cosmetic shipments through the SABER conformity certification platform; not every facility has the export track record.

By formulation depth. If you need ingredient combinations beyond THD ascorbate alone, including peptide stacks, advanced encapsulation, or proprietary cold-pressed botanical oils, Mibelle and Intercos lead. If pre-validated baseline formulas at standard 3, 5, and 10 percent loadings are sufficient, PZIK and Cosmecca shorten timeline by 30 to 60 days.

Always request a full COA, an accelerated stability dossier, and at least one comparable clinic-channel case study before signing. The FDA’s clarification that cosmetics are FDA-regulated but not FDA-approved means substantiation responsibility sits entirely with the brand owner. Your OEM’s documentation depth becomes your defense file.

Frequently Asked Questions

How do we verify the vitamin C in our serum is at functional concentration and not just a label-claim addition?

Request HPLC potency assays at three time points: T0 after fill, T+90 days at 25 degrees C, and T+90 days at 40 degrees C. Functional THD ascorbate begins delivering measurable melanin-index reduction at 3 percent and above; below roughly 1.5 percent the active is generally cosmetic-claim only. A credible OEM provides raw chromatogram data, not just summary tables. Cross-check percent-active loss against the carrier system: anhydrous silicone-ester formats should show less than 8 percent loss at 12 weeks, while aqueous systems degrade faster regardless of supplier.

Will the second and third production runs match the pilot sample in texture, scent, and active potency?

Batch-to-batch consistency is governed by three controls: locked raw-material specifications including single-source THD ascorbate vendor and single carrier-oil grade, in-process viscosity and pH ranges defined in the master batch record, and release-test HPLC for active concentration. Top-tier OEMs lock these into the manufacturing dossier at pilot approval. Ask for their batch deviation tolerance; under plus or minus 5 percent on active and plus or minus 10 percent on viscosity is the professional standard. Decline vendors who will not share their MBR template or release-test SOP.

References

1. U.S. Food and Drug Administration. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved but Are FDA-Regulated. https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated
2. Therapeutic Goods Administration. Cosmetics and the Cosmetic-Therapeutic Boundary. https://www.tga.gov.au/products/unregulated-therapeutic-goods/cosmetics
3. Saudi Standards, Metrology and Quality Organization. SABER Conformity Certification Platform. https://www.saber.sa
4. International Organization for Standardization. ISO 22716:2007 Cosmetics, Good Manufacturing Practices (GMP). Geneva, 2007.
5. U.S. Food and Drug Administration. Sunless Tanners and Bronzers, Cosmetic Ingredients. https://www.fda.gov/cosmetics/cosmetic-ingredients/sunless-tanners-bronzers